Hirtle Callaghan & Co’s CorMedix CRMD Stock Holding History

Hirtle Callaghan & Co’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-51	Closed	-$1K	–	651
2014 Q1	$1K	Buy	+51	New	+$599	﹤0.01%	591
2013 Q4	–	Sell	-51	Closed	–	–	625
2013 Q3	$0	Hold	51	–	–	﹤0.01%	627
2013 Q2	$0	Buy	+51	New	+$184	﹤0.01%	63

Other funds holding CRMD

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Hirtle Callaghan & Co's CRMD Position: Q2 2014 in Review

Hirtle Callaghan & Co sold out of CorMedix (CRMD) in Q2 2014, closing a stake of 51 shares — an estimated $1K sold.

Hirtle Callaghan & Co first reported a position in CRMD in Q2 2013 and held it in 3 quarters. The position peaked at $1K in Q1 2014. 12 funds tracked by Wall St. Rank hold CRMD as of Q2 2014.

Hirtle Callaghan & Co reported no remaining CorMedix position as of Q2 2014 after selling out during the quarter.
Hirtle Callaghan & Co sold 51 CorMedix shares in Q2 2014, an estimated $1K.
Hirtle Callaghan & Co first reported a position in CorMedix in Q2 2013 and held it in 3 quarters.
Hirtle Callaghan & Co's CorMedix position peaked at $1K in Q1 2014.
12 funds tracked by Wall St. Rank held CorMedix as of Q2 2014.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2014, filed 18 Jul 2014.